Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Fennec Pharmaceuticals Inc. Banner

Fennec Pharmaceuticals Inc.

FENC Stock Analysis

Page title

Section title

Breakdown
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Net Income
-2.176m-659.000k-2.789m-7.046m-9.888m-12.775m-18.109m-17.346m-23.714m-16.339m
Depreciation & Amortization
0.0000.0000.0000.0000.00064.000K402.000K14.000K132.000K221.000K
Change in Working Capital
120.000K-63.000k10.000K1.013M132.000K569.000K-763.000k-932.000k1.103M-6.902m
Operating Cash Flow
-1.699m-1.862m-2.124m-3.641m-7.826m-9.060m-15.595m-14.222m-18.058m-17.457m
Capital Expenditure
0.0000.0000.0000.0000.0000.0000.0000.0000.0000.000
Free Cash Flow
-1.699m-1.862m-2.124m-3.641m-7.826m-9.060m-15.595m-14.222m-18.058m-17.457m
Debt Repayment
0.0000.0000.0000.0000.0000.0000.000-4.942m-5.000m-5.092m
Dividends Paid
0.0000.0000.0000.0000.0000.0000.0000.0000.0000.000
Common Stock Issued
2.182M457.742K5.047M27.381M2.210M0.00033.995M-7.930k723.164K1.747M
Common Stock Repurchased
0.0000.0000.0000.0000.0000.0000.0000.000-194.000k-78.000k
Net Change in Cash
644.000K-1.365m2.984M24.334M-5.479m-9.131m16.694M-9.244m2.674M-10.562m